Structures by: Fasulo M. E.
Total: 21
C35H61B11Br6FPRuSi
C35H61B11Br6FPRuSi
Chemical Science (2013) 4, 10 3882
a=11.8239(4)Å b=14.7954(5)Å c=15.4075(5)Å
α=99.3220(10)° β=110.8390(10)° γ=91.5770(10)°
3-(4-pyridyl)-pyrazole, 2,6-difluorobenzoic acid
(C8H7N3)(C7H4F2O2)
Molecular Pharmaceutics (2007) 4, 3 317
a=7.1555(8)Å b=17.958(2)Å c=10.9686(12)Å
α=90.00° β=101.301(2)° γ=90.00°
{1[(1-benzimidazolyl)methyl]-4[(1-pyrazolyl)methyl]benzene}2, succinic acid
(C18H16N4)2(C4H6O4)
Molecular Pharmaceutics (2007) 4, 3 317
a=5.6367(4)Å b=32.910(3)Å c=9.4476(7)Å
α=90.00° β=102.342(6)° γ=90.00°
MF-34-33 3-(4-pyridyl)pyrazole, (Me5-PhCOOH)2
(C8H7N3)(C12H16O2)2
Molecular Pharmaceutics (2007) 4, 3 317
a=8.8864(5)Å b=11.9875(7)Å c=13.7015(8)Å
α=99.3800(10)° β=93.1910(10)° γ=107.5560(10)°
1-[(1-benzimidazolyl)methyl]-3-[(1-pyrazolyl)methyl]benzene (3,5-diNO2PhCOOH)2
(C18H16N4)(C7H4N2O6)2
Molecular Pharmaceutics (2007) 4, 3 317
a=9.7657(6)Å b=11.7691(7)Å c=14.0803(9)Å
α=86.2270(10)° β=74.1630(10)° γ=86.2020(10)°
1,4-bis((1-pyrazolyl)methyl)benzene, (3,5-dinitrobenzoic acid)2
(C14H14N4)(C7H4N2O6)2
CrystEngComm (2006) 8, 8 586
a=12.526(3)Å b=10.179(2)Å c=12.332(3)Å
α=90.00° β=115.038(4)° γ=90.00°
MF142Me8 1,4-bis((3,5-dimethylpyrazol-1-yl)methyl)benzene, (2,6-Cl2PhCOOH)2
(C18H22N4)(C7H4Cl2O2)2
CrystEngComm (2006) 8, 8 586
a=7.5783(8)Å b=7.9010(9)Å c=14.1442(13)Å
α=103.784(7)° β=101.429(7)° γ=90.509(6)°
MF142Me8 1,4-bis((3,5-dimethylpyrazol-1-yl)methyl)benzene (Me5-PhCOOH)2
(C18H22N4)(C12H16O2)2
CrystEngComm (2006) 8, 8 586
a=8.8093(6)Å b=14.7493(10)Å c=15.4238(12)Å
α=67.222(4)° β=82.777(4)° γ=86.232(4)°
C38H78ClO12Si7Ta
C38H78ClO12Si7Ta
Dalton transactions (Cambridge, England : 2003) (2013) 42, 6 1991-1995
a=14.6900(5)Å b=19.0583(6)Å c=21.3387(7)Å
α=105.251(1)° β=107.430(2)° γ=100.373(1)°
C45H84F3O15SSi7Ta
C45H84F3O15SSi7Ta
Dalton transactions (Cambridge, England : 2003) (2013) 42, 6 1991-1995
a=13.252(5)Å b=10.146(5)Å c=44.599(5)Å
α=90.000(5)° β=93.033(5)° γ=90.000(5)°
C39H81O12Si7Ta
C39H81O12Si7Ta
Dalton transactions (Cambridge, England : 2003) (2013) 42, 6 1991-1995
a=10.4766(7)Å b=11.7685(7)Å c=22.1260(15)Å
α=78.832(3)° β=79.710(3)° γ=79.243(3)°
C66H84BF20N2O12Si7Ta
C66H84BF20N2O12Si7Ta
Dalton transactions (Cambridge, England : 2003) (2013) 42, 6 1991-1995
a=14.324(5)Å b=14.832(5)Å c=19.356(5)Å
α=102.447(5)° β=90.694(5)° γ=94.252(5)°
Pg282
C62H78BF20O12Si7Ta
Dalton transactions (Cambridge, England : 2003) (2013) 42, 6 1991-1995
a=13.3982(17)Å b=29.185(4)Å c=40.772(5)Å
α=97.778(7)° β=90.888(8)° γ=92.306(8)°
C20H36F3O3PRuS
C20H36F3O3PRuS
Organometallics (2011) 30, 20 5524
a=17.8310(8)Å b=14.9230(7)Å c=18.0820(8)Å
α=90.00° β=90.00° γ=90.00°
C64H96F5O7P2Ru2S2Si2
C64H96F5O7P2Ru2S2Si2
Organometallics (2011) 30, 20 5524
a=11.229(5)Å b=16.346(5)Å c=18.968(5)Å
α=94.961(5)° β=96.981(5)° γ=95.277(5)°
C32H46F3O3PRuSSi
C32H46F3O3PRuSSi
Organometallics (2011) 30, 20 5524
a=13.379(5)Å b=15.329(6)Å c=16.376(7)Å
α=90.00° β=94.721(5)° γ=90.00°
C37H59P2RhSi
C37H59P2RhSi
Organometallics (2013) 32, 4 1016
a=13.219(10)Å b=13.688(10)Å c=21.101(16)Å
α=90.00° β=107.489(9)° γ=90.00°
C35H61P2RhSi
C35H61P2RhSi
Organometallics (2013) 32, 4 1016
a=16.5825(6)Å b=19.5880(8)Å c=21.8479(9)Å
α=90.00° β=90.00° γ=90.00°
C38H65P2RhSi
C38H65P2RhSi
Organometallics (2013) 32, 4 1016
a=19.6862(27)Å b=9.8564(14)Å c=22.0025(30)Å
α=90.00(0)° β=111.727(2)° γ=90.00(0)°
C41H62ClIrP2Si
C41H62ClIrP2Si
Organometallics (2013) 32, 4 1016
a=14.427(5)Å b=16.079(5)Å c=18.585(5)Å
α=90.000(5)° β=103.041(5)° γ=90.000(5)°
C35H61GeP2Rh
C35H61GeP2Rh
Organometallics (2013) 32, 4 1016
a=16.541(5)Å b=19.613(5)Å c=21.955(5)Å
α=90.000(0)° β=90.000(0)° γ=90.000(0)°